Latest News & Updates
Breaking News
3 hours ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
Enveric Biosciences Achieves Key Safety Milestone for EB-003 Neuroplastogen in Phase I Program
Enveric Biosciences clears a Phase I safety milestone for EB-003, a dual 5-HT2A/5-HT1B neuroplastogen, advancing its clinical development path.
Pharma Now Editorial Team
ACG Showcases Fully Integrated OSD Line at Interpack 2026 in Düsseldorf
ACG demonstrated integrated OSD systems at Interpack 2026, combining compression, packaging, and track-and-trace under one supplier to reduce downtime.
Pharma Now Editorial Team
Teva and Medincell Secure EMA Filing Acceptance for TEV-749 Long-Acting Schizophrenia Injectable
EMA accepts TEV-749 marketing application from Teva and Medincell, advancing a BEPO-platform subcutaneous LAI for schizophrenia into full centralised review.
Pharma Now Editorial Team
Anupam Rasayan Acquires 43.3–48.2% Stake in Bliss GVS Pharma in Vertical Integration Move
Anupam Rasayan acquires a 43.3–48.2% stake in Bliss GVS Pharma, raising GMP alignment and regulatory integration questions for the combined entity.
Pharma Now Editorial Team
